TRACK-TBI Longitudinal Biomarker Study (TRACK-BIO)
Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI)- a Longitudinal Biomarker Study
Sponsor: National Football League
A observational or N/A phase clinical study on Traumatic Brain Injury, this trial is ongoing. The trial is conducted by National Football League and has accumulated 6 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Aug 2025 — Present [monthly]
Active Not Recruiting
Status: Enrolling By Invitation → Active Not Recruiting
-
Sep 2024 — Aug 2025 [monthly]
Enrolling By Invitation
-
Jul 2024 — Sep 2024 [monthly]
Enrolling By Invitation
-
Jul 2023 — Jul 2024 [monthly]
Enrolling By Invitation
-
Jul 2022 — Jul 2023 [monthly]
Enrolling By Invitation
▶ Show 1 earlier version
-
Feb 2022 — Jul 2022 [monthly]
Enrolling By Invitation
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- National Football League
- National Institute of Neurological Disorders and Stroke (NINDS)
- University of Pennsylvania
For direct contact, visit the study record on ClinicalTrials.gov .